Zimmer Biomet
950 hedge funds and large institutions have $17.9B invested in Zimmer Biomet in 2025 Q4 according to their latest regulatory filings, with 124 funds opening new positions, 268 increasing their positions, 370 reducing their positions, and 124 closing their positions.
3.34% more ownership
Funds ownership: 96.97% → 100.31% (+3.3%)
0% more first-time investments, than exits
New positions opened: 124 | Existing positions closed: 124
2% less funds holding
Funds holding: 970 → 950 (-20)
5% less capital invested
Capital invested by funds: $18.9B → $17.9B (-$986M)
28% less repeat investments, than reductions
Existing positions increased: 268 | Existing positions reduced: 370
57% less call options, than puts
Call options by funds: $26.5M | Put options by funds: $61.3M
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Harris Associates
Chicago,
Illinois
|
+$712M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$191M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$64.6M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$52.2M |
| 5 |
SCM
Sio Capital Management
New York
|
+$36.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$138M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$94.8M |
| 3 |
FGP
Freestone Grove Partners
San Francisco,
California
|
-$91.2M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$61.4M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$57.5M |
ZBH Hedge Fund Activity: Q4 2025 in Review
950 of the 8,286 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q4 2025, worth a combined $17.9B — down 5.2% from $18.9B a quarter earlier.
Fund positioning in ZBH was balanced in Q4 2025: 124 funds opened new positions, 124 closed out, 268 added to existing stakes and 370 trimmed.
The largest buyer was Harris Associates, adding an estimated $712M. The largest seller was T. Rowe Price Associates, cutting an estimated $138M.
- 950 institutional investors held Zimmer Biomet (ZBH) as of Q4 2025, down from 970 in Q3 2025.
- Funds reported $17.9B of Zimmer Biomet stock for Q4 2025, down 5.2% quarter-over-quarter.
- 124 funds opened new Zimmer Biomet positions in Q4 2025 and 124 closed out, a net change of 0 holders.
- The largest Zimmer Biomet buyer in Q4 2025 was Harris Associates, an estimated $712M added.
- The largest Zimmer Biomet seller in Q4 2025 was T. Rowe Price Associates, an estimated $138M sold.
Based on aggregated 13F filings for Q4 2025.